Born in New Zealand, Alan has lived and worked in Asia for more than 22years.

Alan has lead businesses across Asia in the Education, HR, SAAS and media sectors. He has been responsible for orchestrating a number of large scale partnerships and development projects Across ASEAN, Japan, Korea and Australasia.

For much of the past decade, Alan held the role of Head of Asia for global Education leader Pearson and is currently Chief Commercial Officer at Nikkei FT Learning, while continuing an active role on our Advisory.

Though his broad experience and active commitment to Diversity, Equality, Inclusion and Belonging, Alan has a strong passion for developing globally mobile talent and is committed to helping people to improve their lives through access to better learning and collaborative opportunities.

Nigel Clarke is the Chair of the General Pharmaceutical Council (GPhC). He started the role in March 2014 after he was appointed by the Privy Council.

Mr Clarke served on the General Osteopathic Council from when it was set up in 1996 until 2008, and he was chair from 2001 to 2007. He was also a member of the Council for Healthcare Regulatory Excellence (now the Professional Standards Authority) from 2003 to 2008. This is the oversight body for the nine health professions regulators, including the GPhC.

In 2007 he chaired the Independent Inquiry into a Future Professional Body for Pharmacy and then the Transitional Committee, which created the prospectus for the reformed Royal Pharmaceutical Society (RPS).

Mr Clarke is senior partner of Learned Lion Partners; chairs the Boards of medical research business Oxford BioElectronics and diagnostics business Attomarker Ltd; and serves on the Advocacy Committee of the European Society of Cardiology.

Mr. Anand Kannan

CEO, Avas Digitech International Pvt Ltd., Global director (IFIA startups department)

Danny Hayes is the CEO and Co-Founder of TerraScale, a green technology company reinventing the future of global sustainable development models. Danny is committed developing sustainable solutions to the world’s most pressing energy and digital infrastructure challenges. He is currently leading various projects at the bleeding edge of technological innovation and sustainable development. TerraScale is currently advised by Goldman Sachs.

Danny’s decades of work in and around sustainable infrastructure, finance, and technology led to his 2021 appointment to the role the Global Program Manager of the European Unions new ImPPPact Program within the C.R.E.A.M. European Unions PPP Alliance.

Danny’s work as the developer of TerraScale’s flagship initiative, Project Energos, has won the 2020 Platinum Outstanding Property Award London, the 2021 ICONIC Innovative Architecture Award and the 2021 Golden Novum Design Award.

Danny also serves as a Financial Advisor to Hudson Capital Advisors, Ambri and FlowCell. He is both a financial advisor and founding partner of the European Union’s C.R.E.A.M. PPP Alliance with the United Nations: visit impppact.org.

In 2020, Danny was appointed Director Emeritus of the non-governmental organization Green Cross. Green Cross is a consultative member of the United Nations on Climate Change and the Conference of the Parties to the United Nations Convention to Combat Desertification.

Danny currently serves as an Advisory Board Member of University of California, Riverside. He is also a member and was the 2021 Gold Sponsor of Top Tier Impact, a global ecosystem of investors, entrepreneurs and professionals who are focused on solving the critical issues of our time.

Danny’s experience includes advising institutions, governments, corporations and individual HNW clientele on developing smart, resilient infrastructure, master planning of industry development, large unit global sales, business negotiations with Fortune 500 companies and lobbying political entities. He was formerly both a LBMA Metals trader (Au) as well as an infrastructure investment banker specialist in structured finance.

Mr. John Norris, JD, MBA, is a globally recognized visionary, thought leader, and craftsman in health policy, law, and management.

He is best known for inventing strategies and products for better methods and means for Life Sciences, Healthcare, and HC IT/AI/ML product development, risk management, regulatory compliance, and crisis management.

He did his early work as COO of the US FDA and as a faculty member at Harvard. He is now a risk management entrepreneur.

Above all, Norris has decades of highly recognized success in very advanced risk management and exceedingly complex problem-solving.

A US President and his Secretary of HHS asked him to co-lead the last major internal reform of the US FDA and the US responses to the Tylenol and Chernobyl crisis.

His Team’s FDA reforms enhanced the FDA’s productivity, timeliness, and ability to significantly cut new-product review times and other costs borne by regulated companies (and the patients they serve).

His FDA, Tylenol, and Chernobyl efforts saved countless lives and dollars.

Also, Norris has facilitated raising billions of dollars to support essential Life Sciences, Healthcare, and Healthcare IT/AI/ML innovations by companies, organizations, and government agencies—in the US and worldwide.

John’s primary skills involve thoughtfully, insightfully, and intuitively listening, validating, analyzing, negotiating, and applying facts and concepts in problematic deal-making, growth-creating, risk-management, or crisis-management settings. Included here is leading the work of others related to envisioning, conceptualizing, negotiating, editing, executing, and enforcing (1) product, branding, or strategic innovations, (2) action plans, (3) marketing/PR plans, (4) fundraising plans, (5) budgets, (6) employment, customer, distributor, manufacturer, warehouser, and funding contracts, (7) enterprise policies, and (8) litigation or regulatory-non-compliance settlement deals.

Click to read more

Desription is here